Proteoglycans in granulomatous lung diseases

European Respiratory Journal

Volumn 10, Issue 12, 1997, Pages 2731-2737

  Bensadoun, E S ^a   Burke, A K ^a   Hogg, J C ^a   Roberts, C R ^a  

^a The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

Author keywords

Extrinsic allergic alveolitis; Proteoglycans; Pulmonary fibrosis; Sarcoidosis; Versican

Indexed keywords

COLLAGEN; PROTEOGLYCAN; VERSICAN;

ALLERGIC PNEUMONITIS; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONNECTIVE TISSUE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG FIBROSIS; LUNG TUBERCULOSIS; PRIORITY JOURNAL; SARCOIDOSIS;

ADULT; AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; BIOLOGICAL MARKERS; CULTURE TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MALE; MIDDLE AGED; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; SARCOIDOSIS, PULMONARY; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY; VERSICANS;

EID: 0031451783     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10122731     Document Type: Article

References (33)

1. Adams DO. The granulomatous inflammatory response. Am J Pathol 1976; 84: 164-191.
2. Hogg JC. Chronic interstitial lung disease of unknown cause: a new classification based on pathogenesis. AJR 1991; 156: 225-233.
3. Peyrol S, Takiya C, Cordier J, Grimaud J. Organization of the connective matrix of the sarcoid granuloma. Ann N Y Acad Sci 1986; 465: 268-285.
4. Bateman E, Turner-Warwick M, Adelmann-Grill BC. Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. Thorax 1981; 36: 645-653.
5. Roberts CR, Wight TN, Hascall VC. Proteoglycans. In: Crystal RG, West JB, Weibel E, Barnes PJ, eds. The Lung: Scientific Foundations, second edition. Philadelphia, Lippincott-Raven, 1997; pp. 757-767.
6. Bensadoun ES, Burke AK, Hogg JC, Roberts CR. Proteoglycan deposition in lung fibrosis. Am J Respir Crit Care Med 1996; 154: 1819-1828.
7. LeBaron RG, Zimmermann DR, Ruoslahti E. Hyaluronate binding properties of versican. J Biol Chem 1992; 267: 10003-10010.
8. Fisher LW, Hawkins GR, Tuross N, Termine JD. Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J Biol Chem 1987; 262: 9702-9708.
9. Fisher LW, Termine JD, Young MF. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 1989; 264: 4571-1576.
10. Adler KB, Low RB, Leslie KO, Mitchell J, Evans JN. Contractile cells in normal and fibrotic lung. Lab Invest 1989; 60: 473-485.
11. Shinomura T, Jensen K, Yamagata M, Kimata K, Solursh M. The distribution of mesenchyme proteoglycan (PG-M) during wing bud outgrowth. Anat Embryol 1990; 181: 227-233.
12. Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis 1989; 9: 1-20.
13. Naso MF, Zimmermann DR, lozzo RV. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J Biol Chem 1994; 269: 32999-33008.
14. Yamagata K, Suzuki S, Akiyama SK, Yamada KM, Kimata K. Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J Biol Chem 1989; 264: 801-806.
15. Yamagata M, Kimata K. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan. PG-M/versican. J Cell Sci 1994; 107: 2581-2590.
16. Hallgren R, Eklund A, Engstrom-Laurent A, Schmekel B. Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. BMJ 1985; 290: 1778-1781.
17. Bjermer L, Engstrom-Laurent A, Lundgren R, Rosenhall L, Hallgren R. Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer's lung. Br Med J 1987; 295: 803-806.
18. Bjermer L, Lundgren R, Hallgren R. Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax 1989; 44: 126-131.
19. Hallgren R, Samuelsson T, Laurent TC, Modig J. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis 1989; 139: 682-687.
20. Nettelbladt O, Hallgren R. Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. Am Rev Respir Dis 1989; 140: 1028-1032.
21. Anderson Bray B, Sampson PM, Osman M, Giandomenico A, Turino GM. Early changes in lung tissue hyaluronan (hyaluronic acid) and hyaluronidase in bleomycin-induced alveolitis in hamsters. Am Rev Respir Dis 1991; 143: 284-288.
22. Nettelbladt O, Tengblad A, Hallgren R. Lung accumulation of hyaluronan parallels pulmonary edema in experimental alveolitis. Am J Physiol 1989; 257: L379-L384.
23. Bhattacharya J, Cruz T, Bhattacharya S, Bray BA. Hyaluronan affects extravascular water in lungs of unanaesthetized rabbits. J Appl Physiol 1989; 66: 2595-2599.
24. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992; 6: 2397-2404.
25. Alho AM, Underbill CB. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol 1989; 108: 1557-1565.
26. van Kuppevelt TH, Cremers FP, Domen JG, van Beuningen HM, van den Brule AJ, Kuyper CM. Ultrastructural localization and characterization of proteoglycans in human lung alveoli. Eur J Cell Biol 1985; 36: 74-80.
27. Fleischmajer R, Fisher LW, MacDonald ED, Jacobs L, Perlish JS, Termine JD. Decorin interacts with fibrillar collagen of embryonic and adult human skin. J Struct Biol 1991; 106: 82-90.
28. Vogel KG, Paulsson M, Heinegärd D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984; 223: 587-597.
29. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281-284.
30. Khalil N, O'Connor RN, Unrnh HW, et al. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991; 5: 155-162.
31. Limper AH, Colby TV, Sanders MS, Asakura S, Roche PC, DeRemee RA. Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994; 149: 197-204.
32. Scott PG, Dodd CM, Tredget EE, Ghahary A, Rahemtulla F. Immunohistochemical localization of the proteoglycan decorin, biglycan and versican and transforming growth factor-beta in human post-burn hypertrophic and mature scars. Histopathology 1995; 26: 423-431.
33. Border WA, Noble NA, Yamamoto T, et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992; 360: 361-364.